ClinicalTrials.Veeva

Menu

Development and Clinical Application of Two New Genetic Deafness Gene Diagnostic Kit

C

Central South University

Status

Unknown

Conditions

Waardenburg Syndrome
Large Vestibular Aqueduct Syndrome

Treatments

Device: gene diagnostic kit

Study type

Observational

Funder types

Other

Identifiers

NCT02418936
2014L01

Details and patient eligibility

About

The purpose of this study is to develop and applicate two new genetic deafness gene diagnostic kit for Waardenburg syndrome and large vestibular aquduct syndrome.

Full description

  1. For the pathogenic gene of Waardenburg syndrome and large vestibular aqueduct syndrome, based on the second-generation sequencing technology, the investigators develop multiplex PCR system for these two hereditary deafness gene diagnostic kit.
  2. Using CNVplex high-throughput gene copy number detection technology to analyse Warrdenburg syndrome pathologic gene. CNVs analysis for Warrdenburg deafness syndrome develop special testing system / kit achieve SNP / CNVs detected simultaneously, as a supplementary means of genetic testing in clinical deafness.

Enrollment

100 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of Waardenburg syndrome
  • Clinical diagnosis of large vestibular aqueduct syndrome

Exclusion criteria

  • Could not be able to exsanguinate

Trial design

100 participants in 2 patient groups

WS
Description:
WS diagositic kit
Treatment:
Device: gene diagnostic kit
LVAS
Description:
LVAS diagositic kit
Treatment:
Device: gene diagnostic kit

Trial contacts and locations

1

Loading...

Central trial contact

Yalan Liu, PhD; Yuxiang Cai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems